Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BACH1 antisense RNA 1 (BACH1-AS1) is a long non-coding RNA (lncRNA) identified in the human genome[2]. Its sequence is cataloged under NCBI Gene ID 106478962[2]. As an antisense transcript to the BACH1 gene, it is distinct from the protein-coding BACH1 transcription factor, which regulates oxidative stress, heme homeostasis, and cell cycle control[1][3][5]. There is currently no published evidence for BACH1-AS1 acting as a therapeutic target, functional RNA, or disease biomarker; its biological role and importance in human health or disease have not been characterized in the scientific databases or literature provided[2]. Notes on ambiguities and correctness: - BACH1-AS1 should not be confused with BACH1, the protein-coding transcription factor, which is well-studied in oxidative stress and cancer[1][3][5]. - The provided data does not support BACH1-AS1 as a therapeutic target or implicated biomolecule in disease. If more detailed experimental or clinical data emerge, these fields may be updated accordingly, but with current evidence, BACH1-AS1 does not correspond to a canonical therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BACH1 antisense RNA 1 (BACH1-AS1).